Ifosfamide and etoposide in previously treated patients with advanced breast cancer

Tumori

Volumn 83, Issue 2, 1997, Pages 604-607

  Kiraz, Sedat ^a   Baltali, Eşmen ^a   Güler, Nilüfer ^a   Barişta, Ibrahim ^a   Benekli, Mustafa ^a,b   Çelik, Ismail ^a   Güllü, Ibrahim H ^a   Kars, Ayşe ^a   Tekuzman, Gülten ^a   Firat, Dinçer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Breast cancer; Etoposide; Ifosfamide

Indexed keywords

ALKYLATING AGENT; ETOPOSIDE; IFOSFAMIDE; MESNA;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; BONE MARROW TOXICITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN;

EID: 0030834165     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300225     Document Type: Conference Paper

References (13)

1. Aisner J., Lee E.J.: Etoposide. Current and future status. Cancer, 67 (suppl.): 215-229, 1991.
2. Cox D.R.: Regression models and life tables. J. Royal Stat. Soc. (B), 34: 187-220, 1972.
3. Harris J.R., Lippman M.E., Veronesi U., Millet W.: Breast cancer: first of three parts. N. Engl. J. Med., 327: 319-328, 1992.
4. Hortobagyi G.N.: Activity of ifosfamide in breast cancer. Semin. Oncol., 19 (suppl. 12): 36-42, 1992.
5. Kaplan E.L., Meier P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
6. Kiraz S., Baltali E., Güler N., Barişta İ., Benekli M., Çelik I., Güllü İ.H., Kars A., Tekuzman G., Firat D.: Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer. J. Chemother., 8: 310-314, 1996.
7. Manegold C., Worst P., Bickel J., Schmid H., Drings P., Kaufmann M.: Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer. Cancer Chemother. Pharmacol., 26 (suppl.): 87-90, 1990.
8. Nichols C.R.: Role of etoposide in treatment of breast cancer. Semin. Oncol., 19 (suppl. 13): 67-71, 1992.
9. Peto R., Pike M.C., Armitage P.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35: 1-39, 1977.
10. Pfeiffer P., Cold S., Rose C.: Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use? Acta Oncol., 31: 219-224, 1992.
11. Sledge G.W.: Etoposide in the management of metastatic breast cancer. Cancer, 67 (suppl.): 266-270, 1991.
12. Sledge G.W., Antman K.H.: Progress in chemotherapy for metastatic breast cancer. Semin. Oncol., 19: 317-332, 1992.
13. World Health Organization: Handbook for reporting results of cancer treatment. Genèva, World Health Organization off-set publication 48, 1979.